Well, if TargeGen Inc is finishing up phase 1 and 2 trials and is worth $75 million up front, and $560 million if approved, we have the starting point for Ariad's '534.. This is absolutely not figured into Ariad's valuation today..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.